BNB Plus Corp.
NASDAQ: BNBX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Clay D. Shorrock
- Employees
- 46
- Headquarters
- Stony Brook, United States
- IPO year
- 2025
- Market cap
- $545.7K
- Website
- https://www.bnbx.io
Loading BNBX…
Loading profile data…Frequently asked questions about BNBX
What does BNB Plus Corp. (BNBX) do?
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Pro...
Where does BNBX trade?
BNB Plus Corp. (BNBX) trades on the NASDAQ Global Market.
What sector is BNBX in?
BNB Plus Corp. (BNBX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BNB Plus Corp.?
Clay D. Shorrock is the chief executive officer of BNB Plus Corp. (BNBX).
Where is BNB Plus Corp. headquartered?
BNB Plus Corp. is headquartered in United States.
Does BNBX pay a dividend?
BNB Plus Corp. (BNBX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BNBX go public?
BNB Plus Corp. (BNBX) completed its initial public offering in 2025.